Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues

Industry leaders from retail pharmacies to health plans to software invited to engage around the theme, 'Commercial Opportunities in the Era of Reform,' from October 29-30

Philadelphia, PA, October 1, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, will host a gathering of some of the industry's most prominent healthcare leaders to discuss issues and trends impacting healthcare today and in the future. The Elsevier Healthcare and Pharmaceutical Economics Conference 2014 will take place in Clearwater Beach, Florida, October 29-30, at the Hyatt Regency Clearwater Beach Resort and Spa. The theme of the two-day conference is "Commercial Opportunities in the Era of Reform."

"Healthcare reform has created both enormous opportunities and challenges that are impacting everything from care delivery and cost to public policy and technology," said Jay Katzen, President, Elsevier Clinical Solutions. "We are excited to present a forum in which those in the forefront of instituting change can present ideas that generate discussion that will continue to shape the current and future healthcare environment."

The two-day conference will consist of multiple sessions and a panel discussion led by industry leaders and Elsevier experts:

  • Healthcare Regulation: Current Status and What's Next in State & Federal Legislation - Adam Huftalen, Government Affairs, Reed Elsevier
  • Specialty Pharmacy and Reimbursement for Drugs under ACA and Outcome-Based Payments - Dean Erhardt, D2 Pharma Consulting
  • Alternative Healthcare Delivery and the Rise of Convenient Care Clinics - Tine Hansen-Turton, Executive Director, Convenient Care Association
  • The Next Big Thing: Genomics and Personalized Medicine - Scott Megill, President, Coriell Life Sciences
  • Current and Future Trends in Pharmaceuticals and Drug Supply Chain - Doug Long, IMS
  • The Empowered Patient: A New Paradigm for Healthcare and Pharmaceutical Marketing - Dorothy Wetzel, extrovetic
  • Taking the Mystery Out of Maximum Allowable Cost with PAC: Addressing the Transparency Trend - Anu Pathria and Todd Grover, Glassbox Analytics
  • Going Mobile: How Far and How Fast Will Healthcare Technology Go? - David Lee Scher, MD, FACC, FHRS, Penn State University College of Medicine and Digital Health Consultants
  • Coming Soon? Update on the Promise of Biosimilars - Ruey Tu, Abbott Laboratories

The Elsevier Healthcare and Pharmaceutical Economics Conference welcomes a wide range of healthcare professionals representing organizations including retail pharmacy chains, health insurance plans and managed care organizations, pharmaceutical manufacturers, medical device manufacturers and government agencies to attend the 2014 conference. Registration fee is $395, including all meals and conference materials.

For more information on attending this event as well as registration, please visit the registration page, https://secure.goldstandard.com/egsdits/.


About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Christopher Capot
Director, Corporate Relations
+1 212 633 3164